Recent News
NewYork-Presbyterian Adopts Signal 1's AI Management System to Advance Healthcare Innovation and Enhance Patient Safety
NewYork-Presbyterian today announced its adoption of Signal 1's AI Management System (AIMS) and plans to work closely with the technology company to support the safe management and monitoring of artificial intelligence technologies across the institution — from tools that help detect cancer and structural heart disease to applications that support discharge planning and clinical documentation.
Columbia University Orthopedics Announces New Physician Leadership Team for Columbia Athletics
The Columbia University Vagelos College of Physicians and Surgeons (VP&S) Department of Orthopedic Surgery today announced a new physician leadership team for Columbia Athletics.
Tumor Organoid Tech Advances Toward a Sci-Fi Future
Significant advances have been made in the development of patient-derived tumor “organoids” for preclinical research, in two new studies led by Weill Cornell Medicine investigators.
Mapping Human Bone Marrow Yields New Tool, Insights on Blood Cancer
Weill Cornell Medicine investigators have developed a new AI-based method to assess patients with a form of blood cancer called myelodysplastic neoplasms.
OpenEvidence and NewYork-Presbyterian, Columbia University and Weill Cornell Medicine Expand Clinical AI Tools Across New York City and Westchester
OpenEvidence, a medical AI and clinical decision support tool for U.S. clinicians, today announced a collaboration with NewYork-Presbyterian and its affiliated medical schools, Columbia University Vagelos College of Physicians and Surgeons and Weill Cornell Medicine, to deploy OpenEvidence across all hospitals and care sites throughout the Greater New York region.
Featured Stories
